Filing Flows › Albemarle (ALB) › Q2 2026 › vs Q2 2025
Albemarle (ALB) Q2 2026 vs Q2 2025 (year over year)
Albemarle's revenue rose $413M (+31%) from $1.3B in Q2 2025 to $1.7B in Q2 2026. Gross margin 33.9% against 14.8% (+19.1 pts).
Albemarle, Q2 2026: revenue $1.7B (+31% year over year), operating margin 26.0%, net earnings $480M, operating cash flow $710M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 33.9% | 14.8% | +19.1 pts |
| Operating margin | 26.0% | 3.6% | +22.4 pts |
| Net margin | 27.5% | 1.7% | +25.8 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.7B | $1.3B | $413M | +31% |
| Gross profit | $590M | $197M | $393M | +200% |
| Cost of revenue | $1.2B | $1.1B | $19.9M | +2% |
| Other income, net | $140M | $21.8M | $119M | +545% |
| Operating profit | $453M | $47.5M | $405M | +853% |
| Operating expenses | $137M | $149M | −$12.0M | -8% |
| Pre-tax earnings | $593M | $69.3M | $524M | +756% |
| Research & development | $3.7M | $12.4M | −$8.8M | -71% |
| SG&A | $126M | $132M | −$6.1M | -5% |
| Other operating costs | $7.3M | $4.4M | $2.9M | +65% |
| Net earnings | $480M | $22.9M | $457M | 21× |
| Minority interests | $19.3M | $12.3M | $7.0M | +57% |
| Income tax | $94.0M | $34.1M | $59.9M | +176% |
| Depreciation & amortization | $156M | $169M | −$12.9M | -8% |
| Share-based compensation | $6.8M | $10.1M | −$3.3M | -33% |
| Working capital & other | $67.5M | −$211M | $278M | — |
| Operating cash flow | $710M | −$9.0M | $719M | — |
Questions
How much did Albemarle's revenue grow year over year in Q2 2026?
Albemarle's revenue rose $413M (+31%) from $1.3B in Q2 2025 to $1.7B in Q2 2026. Gross margin 33.9% against 14.8% (+19.1 pts).